Tag: Lutetium (177Lu) vipivotide tetraxetan

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Lutetium (177Lu) vipivotide tetraxetan

Non-Clinical Study Data Show Potential of FAP-2286 in Tumor Inhibition - Pharmacy Times

Added to Collection on: 2022-04-11 19:44:38

Tags for this article:

Physical sciences
Chemistry
Chemical elements
Radiopharmaceuticals
Medical physics
Orphan drugs
Radiation therapy
Radioactivity
Radiobiology
Lutetium (177Lu) vipivotide tetraxetan
Lutetium
MJH Life Sciences

Click the tags to see associated articles and topics

View Article Details
Metastatic Castration-Sensitive Prostate Cancer Market to Reach Upto USD 5.5 billion by 2032

Added to Collection on: 2022-06-20 16:18:51

Tags for this article:

Life Sciences
Companies
Anatomy
Prostate cancer
Histopathology
Endocyte
Sanofi
Management of prostate cancer
Bristol-Myers Squibb
Prostate
Lutetium (177Lu) vipivotide tetraxetan
Exelixis
Nivolumab
France
Japan
United Kingdom
Firmagon
Germany
Italy
Cabozantinib
DelveInsight Business Research LLP
United States
Niraparib
Spain

Click the tags to see associated articles and topics

View Article Details
Point Bio Prostate Cancer Therapy Meets Phase 3 Goal, But Results Still Disappoint

Added to Collection on: 2023-12-18 23:15:18

Tags for this article:

Medical physics
Eli Lilly and Company
Research and development in the United States
Radiation therapy
Lutetium (177Lu) vipivotide tetraxetan
Prostate cancer
Clinical trial

Click the tags to see associated articles and topics

View Article Details
Real-world data highlight clinical benefit of 177Lu-PSMA-617 in mCRPC - Urology Times

Added to Collection on: 2024-02-05 21:18:12

Tags for this article:

Prostate cancer
Radiation therapy
Radiopharmaceuticals
Lutetium (177Lu) vipivotide tetraxetan
Gallium
Radium-223
PSMA scan
Glutamate carboxypeptidase II

Click the tags to see associated articles and topics

View Article Details
Study launches of BNT316/ONC-392 plus radioligand therapy in mCRPC - Urology Times

Added to Collection on: 2024-02-22 21:08:48

Tags for this article:

Radiopharmaceuticals
Prostate cancer
Lutetium (177Lu) vipivotide tetraxetan
Lutetium
Glutamate carboxypeptidase II
Androgen deprivation therapy
Advanced Accelerator Applications
PSMA scan
OncoC4 Inc.

Click the tags to see associated articles and topics

View Article Details
OncoC4 Announces First Patient with Advanced Prostate Cancer Dosed in Phase 1/2 ... - Morningstar

Added to Collection on: 2024-02-22 13:17:50

Tags for this article:

Prostate cancer
Lutetium (177Lu) vipivotide tetraxetan
Radiopharmaceuticals
Glutamate carboxypeptidase II
Targeted therapy
Cancer treatment
Prostvac
Advanced Accelerator Applications
OncoC4 Inc.
BioNTech

Click the tags to see associated articles and topics

View Article Details
OncoC4 Announces First Patient with Advanced Prostate - GlobeNewswire

Added to Collection on: 2024-02-22 13:14:51

Tags for this article:

Prostate cancer
Lutetium (177Lu) vipivotide tetraxetan
Radiopharmaceuticals
Glutamate carboxypeptidase II
Targeted therapy
Cancer treatment
Prostvac
Advanced Accelerator Applications
OncoC4 Inc.
BioNTech

Click the tags to see associated articles and topics

View Article Details
AstraZeneca to acquire radioconjugate biotech Fusion in $2.4bn deal

Added to Collection on: 2024-03-19 19:52:03

Tags for this article:

AstraZeneca
Medical research
Södertälje Municipality
Novartis
Lutetium (177Lu) vipivotide tetraxetan
Oxford–AstraZeneca COVID-19 vaccine
Bristol-Myers Squibb
Oncology
Pharmaceutical industry in China
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST ...

Added to Collection on: 2024-04-09 20:06:17

Tags for this article:

Prostate cancer
Radiopharmaceuticals
Lutetium (177Lu) vipivotide tetraxetan
Glutamate carboxypeptidase II
Lutetium
PSMA scan
Fusion Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details